相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy of Silexan in mixed anxiety-depression - A randomized, placebo-controlled trial
Siegfried Kasper et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep - A randomized, placebo-controlled trial
Siegfried Kasper et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
Pia Baldinger et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review
Heidemarie Haller et al.
BMC PSYCHIATRY (2014)
Lavender oil preparation Silexan is effective in generalized anxiety disorder - a randomized, double-blind comparison to placebo and paroxetine
Siegfried Kasper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination
Doris Heger-Mahn et al.
DRUGS IN R&D (2014)
Anxiolytic-like effect of lavender essential oil inhalation in mice: Participation of serotonergic but not GABAA/benzodiazepine neurotransmission
Lea R. Chioca et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Silexan, an essential oil from flowers of Lavandula angustifolia, is not recognized as benzodiazepine-like in rats trained to discriminate a diazepam cue
Leo B. Silenieks et al.
PHYTOMEDICINE (2013)
Lavender Oil-Potent Anxiolytic Properties via Modulating Voltage Dependent Calcium Channels
Anita M. Schuwald et al.
PLOS ONE (2013)
Characterization of anxiolytic and neuropharmacological activities of Silexan
Vikas Kumar
WIENER MEDIZINISCHE WOCHENSCHRIFT (2013)
Drug Cocktail Interaction Study on the Effect of the Orally Administered Lavender Oil Preparation Silexan on Cytochrome P450 Enzymes in Healthy Volunteers
Oxana Doroshyenko et al.
DRUG METABOLISM AND DISPOSITION (2013)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies
N. J. Kalk et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Stress, glucocorticoids and glutamate release: Effects of antidepressant drugs
Laura Musazzi et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial
Siegfried Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder
H. Woelk et al.
PHYTOMEDICINE (2010)
Physician Withdrawal Checklist (PWC-20)
Karl Rickels et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Anxiety disorders in primary care:: Prevalence, impairment, comorbidity, and detection
Kurt Kroenke et al.
ANNALS OF INTERNAL MEDICINE (2007)
Discontinuation symptoms in depression and anxiety disorders
David S. Baldwin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Anxiety disorders: Sex differences in prevalence, degree, and background, but gender-neutral treatment
Marrie H. J. Bekker et al.
GENDER MEDICINE (2007)
Prevalence and treatment of mental disorders, 1990 to 2003
RC Kessler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease
F Bonnet et al.
ATHEROSCLEROSIS (2005)
The prevalence and co-morbidity of subthreshold psychiatric conditions
PM Lewinsohn et al.
PSYCHOLOGICAL MEDICINE (2004)
One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample
RM Carter et al.
DEPRESSION AND ANXIETY (2001)
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey
HU Wittchen et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)